Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GemPharmatech
Nanjing, Jiangsu, Chinaen.gempharmatech.com ↗
- Ownership
- Public · 688046
- Employees
- ~1578
- Development stage
- Commercial
01
Overview
GemPharmatech does not develop its own clinical-stage therapeutics but provides essential genetically engineered mouse models and related services that support global biomedical research and drug development. The company has one of the world’s largest libraries of KO/cKO mice, humanized mice, immunodeficient mice, and germ-free mice. No direct clinical results as it does not run its own drug programs.
- Modalities
- Animal model (genetically engineered mouse models)Gene editing technologyHumanized animal modelsSmall molecule (as part of pharmacology services, but not a direct product)
- Industry
- Drug Discovery Services
Beyond the preview
Go deeper on GemPharmatech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GemPharmatech.